FDA approved use of the 05 mL dose of Sanofi’s Fluzone Quadrivalent influenza vaccine to include children age 6 through 35 months
On Jan. 23, 2019, U.S. Food and Drug Administration (FDA) announced it had approved approved the use of…
TESARO was acquired by GSK for $5.1 billion
On Jan. 22, 2019, GlaxoSmithKline acquired TESARO based in Waltham, Massachusetts, for an aggregate cash consideration of approximately…
Researchers discovered way to kill dormant, hiding breast cancer cells, an avenue for preventing relapse
On Jan. 21, 2019, researchers at Fred Hutchinson Cancer Research Center announced finding a way to essentially smother…
Masonic Cancer Center researchers received $1.4 million in grants for ovarian cancer research
On Jan. 18, 2019, Masonic Cancer Center researchers received $1.4 million in grants for ovarian cancer research from…
Masonic Cancer Center researcher Branden Moriarity, PhD, received U24 Grant with Recombinetics, Inc
On Jan. 18, 2019, Masonic Cancer Center researcher Branden Moriarity, PhD, received a U24 Grant with Recombinetics. The…
FDA approved expanded use of Sanofi’s Adacel Tdap vaccine for a second dose in people ages 10 through 64 years of age
On Jan. 14, 2019, Sanofi announced the FDA had approved the expanded use of Adacelﾮ (Tetanus Toxoid, Reduced…
AstraZeneca closed Boulder-based LakeCentre and Longmont facilities
On Jan. 9, 2019, AstraZeneca announced it had closed plants in Colorado and layed off 210 workers. AstraZeneca…
Takeda Pharmaceutical acquired Shire
On Jan. 8, 2019, Takeda Pharmaceutical announced the completion of its acquisition of Lexington, Massachusetts-based Shire for a…
Emory University School of Medicine received a $500,000 grant from CDC to research children’s recovery from mild traumatic brain injury (mTBI)
On Jan. 7, 2019, the Emory University School of Medicine received a $500,000 grant from the Centers for…
The Martin Health System was founded
In 1939, Martin Health was founded in 1939 with an original hospital that had 23 beds, three physicians,…
Calibr began using robotics to speed drug discovery
In 2019, Calibr began using robotics as an emerging drug discovery model to accelerate new medicines and fund…
The Quebec Scientific Entrepreneurship Program was launched
In 2019, the Quebec Scientific Entrepreneurship Program (QcSE) launched as an online program for scientists and STEM researchers…
Biotechnology | FDA | Infectious Disease | Polio | Vaccine
FDA approved Vaxelis, a new combination DTaP-IPV-Hib-HepB vaccine for use in children 6 wks-4 yrs of age
On Dec. 26, 2018, Sanofi announced the U.S. Food and Drug Administration (FDA) had approved VAXELIS (Diphtheria and…
Karmanos Cancer Institute and Wayne State University awarded prestigious LAPS grant
On Dec. 20, 2018, the Karmanos Cancer Institute and Wayne State University were awarded the prestigious LAPS Grant…
Karmanos Morey Cancer Center recognized by the American Society of Clinical Oncology with the QOPI Certification Program
On Dec. 17, 2018, the Karmanos Morey Cancer Center was recognized by the American Society of Clinical Oncology…
The Allen Institute for Immunology was Founded
On Dec. 12, 2018, the Allen Institute announced the launch of the Allen Institute for Immunology, a new…
Record $50 million gift to Virginia Tech results in naming of the Fralin Biomedical Research Institute in Roanoke
On Dec. 6, 2018, the Horace G. Fralin Charitable Trust and Heywood and Cynthia Fralin donated a record…
Seqirus’ Next Generation Cell-based Influenza Vaccine Shows Significantly Greater Effectiveness Compared to Standard Egg-based Options in the 2017-18 US Influenza Season
On Dec. 5, 2018, Seqirus, a CSL subsidiary, announced real-world data showing that its cell-based quadrivalent influenza vaccine…
Biotechnology | Disease | Genomics | Oncology | Therapeutics
The UK announced sequencing 100,000 whole genomes in the National Health Service
On Dec. 5, 2018, Genomics England announced the 100,000 Genomes Project, done in partnership with National Health Service…
A UCLA-led research team identified genetic processes involved in the neurodegeneration that occurs in dementiaﾠ
On Dec 3, 2018, a University of California, Los Angeles (UCLA) led research team announced they had identified…
University of South Carolina awarded CDC grant to study the risk of human exposure to environmental antibiotic resistant bacteria
On Nov. 30, 2018, Sean Norman, associate professor of environmental health sciences and director of the Molecular Microbial…
Washington University School of Medicine gifted $20 million to boost multiple myeloma research
On Nov. 29, 2018, St. Louis native Rodger Riney and his wife, Paula, donated $20 million to research…
FDA approved gilteritinib, a targeted drug for leukemia tested at UPenn
On Nov. 28, 2018, The U.S. Food and Drug Administration (FDA) announced it had approved the first ever…
Canadian Cancer Trials Group announced IND.234 clinical trial using liquid biopsy technology for prostrate cancer screening
On Nov. 27, 2018, the Canadian Cancer Trials Group, a new clinical trial, opened across Canada. This was…
The Abramson Cancer Center joined the National Comprehensive Cancer Network as its 28th member institution
On Nov. 20, 2018, the Abramson Cancer Center joined the National Comprehensive Cancer Networkﾮ (NCCN) as its 28th…
Prime Minister Trudeau announced federal funding for the Institute for Advanced Medical Isotopes
On Nov. 13, 2018, Canadian Prime Minister Justin Trudeau announced federal funding for the Institute for Advanced Medical…
Mayo Clinic School of Medicine received $200 million gift
On Nov. 13, 2018, the Mayo Clinic announced a gift of $200 million from Jay Alix, noted philanthropist…
Pascal Biosciences announced optimization of cannabinoid-derived drug candidates to kill glioblastoma cells
On Nov. 5, 2018, Pascal Biosciences announced the peer reviewed publication of their licensed cannabinoid-derived drug program for…
Biotechnology | CDC | Disease | Vaccine
ACIP published updated recommendations on use of hepatitis A vaccine for pre- and post-exposure prophylaxis for international travel
On Nov. 2, 2018, the Immunization Practices Advisory Committee (ACIP) published updated recommendations on use of hepatitis A…
AcelRx pharmaceutical DSUVIA was approved by FDA
On Nov. 2, 2018, AcelRx pharmaceutical’s DSUVIA was approved by U.S. Food and Drug Administration (FDA). DSUVIA is…